LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11

Search options

  1. Article ; Online: Management and Clinical Outcomes of 37 Patients with Necrotizing Otitis Externa: Retrospective Review of a Standardized 6-Week Treatment Pathway.

    Dhariwal, Ankush / Manjaly, Joseph G / Patel, Bhavesh / Morris-Jones, Stephen / David, Kate / Khetarpal, Priya / Beale, Tim / Mehta, Nishchay / Logan, Sarah

    The journal of international advanced otology

    2023  Volume 19, Issue 3, Page(s) 223–227

    Abstract: Background: Necrotizing otitis externa is an invasive infection, affecting older patients, with significant associated morbidity. Despite this, there are no randomized controlled trials that address management, and therefore, treatment approaches may ... ...

    Abstract Background: Necrotizing otitis externa is an invasive infection, affecting older patients, with significant associated morbidity. Despite this, there are no randomized controlled trials that address management, and therefore, treatment approaches may vary considerably. We describe the management and outcomes of 37 patients managed using a multidisciplinary treatment pathway for necrotizing otitis externa over a 5-year period. The pathway is based on a standardized antibiotic regime of 3 weeks of intravenous ceftazidime plus oral ciprofloxacin, followed by a further 3 weeks of ciprofloxacin.
    Methods: This is a retrospective review of all patients diagnosed with necrotizing otitis externa since the introduction of our pathway in 2016. We include data on patient demographics, comorbidities, microbiology, length of stay, and length of antimicrobial treatment. Outcome data, including mortality, relapse and treatment failure, and adverse effects of treatment, are presented.
    Results: The median age of our patients was 82 years. About 54% of patients had diabetes mellitus or another cause of immunocompromise. Pseudomonas aeruginosa was isolated in 68%. The median duration of inpatient stay was 9 days, and median treatment duration was 6 weeks. Of 37 patients, 32 were cured (86%), and of the remaining 5 patients, there were 2 mortalities unrelated to necrotizing otitis externa and 3 patients with recurrent infections due to anatomical abnormalities.
    Conclusion: We note favorable treatment outcomes when using a standardized multidisciplinary pathway and a 6-week course of antibiotic therapy.
    MeSH term(s) Humans ; Aged, 80 and over ; Otitis Externa/drug therapy ; Otitis Externa/microbiology ; Retrospective Studies ; Ciprofloxacin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Ceftazidime/therapeutic use ; Pseudomonas Infections/drug therapy ; Pseudomonas Infections/complications
    Chemical Substances Ciprofloxacin (5E8K9I0O4U) ; Anti-Bacterial Agents ; Ceftazidime (9M416Z9QNR)
    Language English
    Publishing date 2023-06-05
    Publishing country Turkey
    Document type Journal Article
    ZDB-ID 2561231-1
    ISSN 2148-3817 ; 1308-7649 ; 2148-3817
    ISSN (online) 2148-3817
    ISSN 1308-7649 ; 2148-3817
    DOI 10.5152/iao.2023.22637
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Response to Author Comments on "Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase-producing Enterobacterales blood stream infections".

    Anton-Vazquez, Vanesa / Evans, Terry John / Fernando, Samitha / Somasunderam, Donald / David, Kate / Melzer, Mark / Hawkins, Lois / Morris-Jones, Stephen / Arias, Mauricio / Drazho, Borana / Dall'Antonia, Martino / Planche, Timothy

    Infection prevention in practice

    2023  Volume 5, Issue 4, Page(s) 100327

    Language English
    Publishing date 2023-11-17
    Publishing country England
    Document type Journal Article
    ISSN 2590-0889
    ISSN (online) 2590-0889
    DOI 10.1016/j.infpip.2023.100327
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase-producing Enterobacterales bloodstream infections: a multicentre study.

    Anton-Vazquez, Vanesa / Evans, Terry John / Fernando, Samitha / Somasunderam, Donald / David, Kate / Melzer, Mark / Hawkins, Lois / Morris-Jones, Stephen / Arias, Mauricio / Drazho, Borana / Dall'Antonia, Martino / Planche, Timothy

    Infection prevention in practice

    2023  Volume 5, Issue 3, Page(s) 100298

    Abstract: Objectives: To investigate the clinical, microbiological characteristics and outcomes of patients with bloodstream infections (BSI) due to carbapenemase-producing Enterobacterales (CPE).: Methods: A multicentre retrospective observational study of ... ...

    Abstract Objectives: To investigate the clinical, microbiological characteristics and outcomes of patients with bloodstream infections (BSI) due to carbapenemase-producing Enterobacterales (CPE).
    Methods: A multicentre retrospective observational study of patients with BSIs due to CPE admitted to six UK hospitals was conducted between 2011 and 2021. Multivariate analysis was used to identify factors predicting 30-day case fatality rate (CFR).
    Results: There were 84 episodes of CPE-BSIs, 37 (44%) due to OXA-48, 35 (42%) to metallo-betalactamases (MBL) and 12 (14%) to KPC. 63% of patients were male with a median age of 64 years. Common organisms included
    Conclusion: Strategies targeting high-risk patients and adherence to infection prevention bundles for urinary devices and central venous catheters can reduce OXA-48 and KPC-BSIs. Early recognition and management of severe sepsis, prompt initiation of appropriate antimicrobial therapy and development of novel antimicrobials are crucial to mitigate the high CFR associated with CPE-BSIs
    Language English
    Publishing date 2023-07-08
    Publishing country England
    Document type Journal Article
    ISSN 2590-0889
    ISSN (online) 2590-0889
    DOI 10.1016/j.infpip.2023.100298
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Predictors during childhood of future health-related quality of life in adults with Gilles de la Tourette syndrome.

    Cavanna, Andrea E / David, Kate / Orth, Michael / Robertson, Mary M

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

    2012  Volume 16, Issue 6, Page(s) 605–612

    Abstract: Background: Gilles de la Tourette syndrome (GTS) is a chronic neurodevelopmental disorder characterised by multiple motor and phonic tics and behavioural problems. Patients with GTS of all ages often report a poor health-related quality of life (HR-QOL). ...

    Abstract Background: Gilles de la Tourette syndrome (GTS) is a chronic neurodevelopmental disorder characterised by multiple motor and phonic tics and behavioural problems. Patients with GTS of all ages often report a poor health-related quality of life (HR-QOL). The diagnosis of GTS is usually established in childhood but little is known about factors that predict the long-term well-being of patients, especially in the presence of co-morbid behavioural problems.
    Aim: To investigate the childhood predictors of HR-QOL in a cohort of adult patients with GTS.
    Methods: Forty-six patients with GTS aged 6-16 years underwent a baseline standardised clinical assessment of both tics and behavioural symptoms at a specialist GTS clinic. The same patients were re-assessed aged 16 years and above, with a mean follow-up period of 13 years (range 3-25 years), when they completed the Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL), a disease-specific measure of HR-QOL.
    Results: Tic severity, premonitory urges and family history of GTS were identified as predictors during childhood of a poorer HR-QOL in adults with GTS by multiple linear regression analysis. Specifically, tic severity significantly predicted poor outcome across physical, psychological and cognitive domains of the GTS-QOL, reflecting widespread effects on HR-QOL.
    Conclusion: Young patients with severe tics associated with characteristic premonitory urges and a family history of tic disorders appear to be at higher risk for poorer HR-QOL as adults. Further prospective research into HR-QOL in GTS is required in order to inform long-term strategic resource allocation.
    MeSH term(s) Adolescent ; Adult ; Aged ; Child ; Cross-Sectional Studies ; Data Interpretation, Statistical ; Demography ; Female ; Humans ; Interview, Psychological ; Longitudinal Studies ; Male ; Middle Aged ; Neuropsychological Tests ; Obsessive-Compulsive Disorder/complications ; Obsessive-Compulsive Disorder/psychology ; Prognosis ; Quality of Life/psychology ; Regression Analysis ; Resource Allocation ; Tourette Syndrome/complications ; Tourette Syndrome/psychology ; Treatment Outcome ; Young Adult
    Language English
    Publishing date 2012-11
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1397146-3
    ISSN 1532-2130 ; 1090-3798
    ISSN (online) 1532-2130
    ISSN 1090-3798
    DOI 10.1016/j.ejpn.2012.02.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.

    Fox, Thomas A / Troy-Barnes, Ethan / Kirkwood, Amy A / Chan, Wei Y / Day, James W / Chavda, Selina J / Kumar, Emil A / David, Kate / Tomkins, Oliver / Sanchez, Emilie / Scully, Marie / Khwaja, Asim / Lambert, Jonathan / Singer, Mervyn / Roddie, Claire / Morris, Emma C / Yong, Kwee L / Thomson, Kirsty J / Ardeshna, Kirit M

    British journal of haematology

    2020  Volume 191, Issue 3, Page(s) 505–506

    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections ; Critical Illness ; Humans ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-10-26
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/bjh.17110
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy.

    Fox, Thomas A / Troy-Barnes, Ethan / Kirkwood, Amy A / Chan, Wei Yee / Day, James W / Chavda, Selina J / Kumar, Emil A / David, Kate / Tomkins, Oliver / Sanchez, Emilie / Scully, Marie / Khwaja, Asim / Lambert, Jonathan / Singer, Mervyn / Roddie, Claire / Morris, Emma C / Yong, Kwee L / Thomson, Kirsty J / Ardeshna, Kirit M

    British journal of haematology

    2020  Volume 191, Issue 2, Page(s) 194–206

    Abstract: Haematology patients receiving chemo- or immunotherapy are considered to be at greater risk of COVID-19-related morbidity and mortality. We aimed to identify risk factors for COVID-19 severity and assess outcomes in patients where COVID-19 complicated ... ...

    Abstract Haematology patients receiving chemo- or immunotherapy are considered to be at greater risk of COVID-19-related morbidity and mortality. We aimed to identify risk factors for COVID-19 severity and assess outcomes in patients where COVID-19 complicated the treatment of their haematological disorder. A retrospective cohort study was conducted in 55 patients with haematological disorders and COVID-19, including 52 with malignancy, two with bone marrow failure and one immune-mediated thrombotic thrombocytopenic purpura (TTP). COVID-19 diagnosis coincided with a new diagnosis of a haematological malignancy in four patients. Among patients, 82% were on systemic anti-cancer therapy (SACT) at the time of COVID-19 diagnosis. Of hospitalised patients, 37% (19/51) died while all four outpatients recovered. Risk factors for severe disease or mortality were similar to those in other published cohorts. Raised C-reactive protein at diagnosis predicted an aggressive clinical course. The majority of patients recovered from COVID-19, despite receiving recent SACT. This suggests that SACT, where urgent, should be administered despite intercurrent COVID-19 infection, which should be managed according to standard pathways. Delay or modification of therapy should be considered on an individual basis. Long-term follow-up studies in larger patient cohorts are required to assess the efficacy of treatment strategies employed during the pandemic.
    MeSH term(s) Adult ; Age Factors ; Aged ; Aged, 80 and over ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/therapeutic use ; Blacks ; COVID-19/complications ; COVID-19/mortality ; COVID-19/therapy ; Comorbidity ; Cross Infection/complications ; Female ; Hematologic Diseases/complications ; Hematologic Diseases/drug therapy ; Hematologic Diseases/mortality ; Hematologic Diseases/therapy ; Hematopoietic Stem Cell Transplantation ; Humans ; Immunotherapy ; Leukemia/complications ; Leukemia/drug therapy ; Leukemia/mortality ; London/epidemiology ; Lymphoma/complications ; Lymphoma/drug therapy ; Lymphoma/mortality ; Male ; Middle Aged ; Respiration, Artificial ; Retrospective Studies ; Risk Factors ; SARS-CoV-2 ; Thrombophilia/drug therapy ; Thrombophilia/etiology ; Treatment Outcome ; Young Adult
    Chemical Substances Antineoplastic Agents
    Keywords covid19
    Language English
    Publishing date 2020-08-12
    Publishing country England
    Document type Journal Article
    ZDB-ID 80077-6
    ISSN 1365-2141 ; 0007-1048
    ISSN (online) 1365-2141
    ISSN 0007-1048
    DOI 10.1111/bjh.17027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Health-related quality of life in Gilles de la Tourette syndrome: a decade of research.

    Cavanna, Andrea Eugenio / David, Kate / Bandera, Valentina / Termine, Cristiano / Balottin, Umberto / Schrag, Anette / Selai, Caroline

    Behavioural neurology

    2012  Volume 27, Issue 1, Page(s) 83–93

    Abstract: Gilles de la Tourette syndrome (GTS) is a neurodevelopmental condition characterised by multiple motor and phonic tics and associated behavioural problems, carrying a significant burden on patients' lives. Although the term health related-quality of life ...

    Abstract Gilles de la Tourette syndrome (GTS) is a neurodevelopmental condition characterised by multiple motor and phonic tics and associated behavioural problems, carrying a significant burden on patients' lives. Although the term health related-quality of life (HR-QOL) has only been used in recent years, several studies have long addressed the impact of GTS on physical, psychological and social aspects of wellbeing of both children and adults with GTS. We set out to answer the question "Is HR-QOL affected by GTS and, if so, in what domains?" by conducting a systematic literature review of published original studies addressing HR-QOL in both children and adult patients with GTS. This review focuses on the current evidence on the impact of GTS on patients' lives, mainly informed by studies using generic functional impairment and HR-QOL measures from the last decade, and expands on the new opportunities introduced by the recently developed GTS-specific HR-QOL scales (GTS-QOL and GTS-QOL-C&A). Analysis of the first decade of studies specifically addressing HR-QOL in GTS suggests that co-morbid conditions are key factors in determining HR-QOL in young patients, whilst the picture is more complex in adults with GTS. These findings offer some general directions for both current clinical practice and future research.
    MeSH term(s) Comorbidity ; Humans ; Mental Disorders/epidemiology ; Mental Disorders/psychology ; Quality of Life/psychology ; Tourette Syndrome/epidemiology ; Tourette Syndrome/psychology
    Language English
    Publishing date 2012-11-26
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review ; Systematic Review
    ZDB-ID 1001896-7
    ISSN 1875-8584 ; 0953-4180
    ISSN (online) 1875-8584
    ISSN 0953-4180
    DOI 10.3233/BEN-120296
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Survey of Pediatricians and Early Hearing Detection and Identification Programs at a Precise Local Level: An Academic Medical Center

    Danhauer, Jeffrey L / David, Kate B / Johnson, Carole E / Meyer, Dianne H

    Seminars in Hearing

    2009  Volume 30, Issue 03, Page(s) 165–183

    Abstract: Pediatricians (Peds) are vital to early hearing detection and intervention programs (EHDIPs). Peds should educate families about programs and encourage them to comply with professionals' recommendations. Surveying Peds at local levels is important for ... ...

    Abstract Pediatricians (Peds) are vital to early hearing detection and intervention programs (EHDIPs). Peds should educate families about programs and encourage them to comply with professionals' recommendations. Surveying Peds at local levels is important for ensuring that they meet benchmarks. This study used a revised questionnaire to assess Peds at Rush University Medical Center (RUMC) about EHDIPs. Of all 115 Peds at RUMC, 21 responded = 18.6% response rate; 57% (12) were residents and 42.9% (9) were attending physicians. Most had knowledge about, experience with, and positive attitudes toward EHDIPs, but could use additional information. Results expanded on earlier surveys by using an updated questionnaire relevant to latest EHDIPs goals and Peds at a precise hospital and provided information for audiologists conducting physician outreach programs to help Peds prevent children from being lost to follow up.
    Keywords Benchmarks ; continuing medical education ; early hearing detection and intervention programs ; newborn hearing screening programs ; pediatricians ; physicians' impressions ; questionnaire
    Language English
    Publishing date 2009-08-01
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 604961-8
    ISSN 1098-8955 ; 0734-0451
    ISSN (online) 1098-8955
    ISSN 0734-0451
    DOI 10.1055/s-0029-1225402
    Database Thieme publisher's database

    More links

    Kategorien

  9. Article: Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'

    Fox, Thomas A / Troy-Barnes, Ethan / Kirkwood, Amy A / Chan, Wei Y / Day, James W / Chavda, Selina J / Kumar, Emil A / David, Kate / Tomkins, Oliver / Sanchez, Emilie / Scully, Marie / Khwaja, Asim / Lambert, Jonathan / Singer, Mervyn / Roddie, Claire / Morris, Emma C / Yong, Kwee L / Thomson, Kirsty J / Ardeshna, Kirit M

    Br J Haematol

    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #889708
    Database COVID19

    Kategorien

  10. Article: Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy

    Fox, Thomas A / Troy-Barnes, Ethan / Kirkwood, Amy A / Chan, Wei Yee / Day, James W / Chavda, Selina J / Kumar, Emil A / David, Kate / Tomkins, Oliver / Sanchez, Emilie / Scully, Marie / Khwaja, Asim / Lambert, Jonathan / Singer, Mervyn / Roddie, Claire / Morris, Emma C / Yong, Kwee L / Thomson, Kirsty J / Ardeshna, Kirit M

    Br. j. haematol

    Abstract: Haematology patients receiving chemo- or immunotherapy are considered to be at greater risk of COVID-19-related morbidity and mortality. We aimed to identify risk factors for COVID-19 severity and assess outcomes in patients where COVID-19 complicated ... ...

    Abstract Haematology patients receiving chemo- or immunotherapy are considered to be at greater risk of COVID-19-related morbidity and mortality. We aimed to identify risk factors for COVID-19 severity and assess outcomes in patients where COVID-19 complicated the treatment of their haematological disorder. A retrospective cohort study was conducted in 55 patients with haematological disorders and COVID-19, including 52 with malignancy, two with bone marrow failure and one immune-mediated thrombotic thrombocytopenic purpura (TTP). COVID-19 diagnosis coincided with a new diagnosis of a haematological malignancy in four patients. Among patients, 82% were on systemic anti-cancer therapy (SACT) at the time of COVID-19 diagnosis. Of hospitalised patients, 37% (19/51) died while all four outpatients recovered. Risk factors for severe disease or mortality were similar to those in other published cohorts. Raised C-reactive protein at diagnosis predicted an aggressive clinical course. The majority of patients recovered from COVID-19, despite receiving recent SACT. This suggests that SACT, where urgent, should be administered despite intercurrent COVID-19 infection, which should be managed according to standard pathways. Delay or modification of therapy should be considered on an individual basis. Long-term follow-up studies in larger patient cohorts are required to assess the efficacy of treatment strategies employed during the pandemic.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #650898
    Database COVID19

    Kategorien

To top